Forest's Lercanidipine Falls Short In Hypertension Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
The calcium channel blocker "did not meet all the stringent preset criteria for dose response," and Forest plans to develop an alternative formulation. Company downgrades its earnings forecast following approval of Celexa generics; Forest's Inwood Labs division is marketing its own citalopram generic.
You may also be interested in...
Purepac Offers Cheapest Celexa Generic
The average wholesale price of Purepac's citalopram tablets is a 14% discount to the brand. Forest took a 5% price increase on Celexa prior to the approval of several generics at the end of October.
Purepac Offers Cheapest Celexa Generic
The average wholesale price of Purepac's citalopram tablets is a 14% discount to the brand. Forest took a 5% price increase on Celexa prior to the approval of several generics at the end of October.
Celexa Generics Clear FDA
Five ANDAs for generic versions of Forest’s antidepressant approved; 180-day exclusivity was not available. Forest has been transitioning patients to the follow-on agent Lexapro.